Ultrasound score to predict anti-TNF success in IBD
Part of Digestive system clinical trials.
This study tests whether an ultrasound score (called VAT) combined with another ultrasound score (IUS) can predict how well anti-TNF medications (like infliximab) work for people with inflammatory bowel disease. If you are starting a new anti-TNF treatment, this study may help doctors understand if the medication will be effective for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have active inflammatory bowel disease (Crohn's disease or ulcerative colitis), either newly diagnosed or a flare.
- Your doctor plans to start you on an anti-TNF medication (like infliximab or adalimumab) within a month after a colonoscopy.
- You have never had abdominal surgery.
- You do not have active infections, heart failure, nerve disorders, or allergies to the contrast agent used in the study ultrasound.
- You are not pregnant or breastfeeding, and you are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses intestinal ultrasound to see if vedolizumab can heal the gut in people recently diagnosed with Crohn's disease. It aims to find early signs that the treatment is working.
This trial tests if a medication called Guselkumab can help people with moderate to severe Crohn's disease. It uses a special ultrasound to see how the bowel responds to treatment.
This study tests whether a special ultrasound of the intestines can predict when Crohn's disease will flare up again in patients whose disease is currently well-controlled. If successful, doctors could catch flare-ups earlier and adjust treatment before symptoms worsen.
This study tests whether using ultrasound to guide treatment can help manage inflammatory bowel disease. You may join if you are having an endoscopy to assess your disease.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at different ways to measure the amount of biologic drugs in your blood. It is for people with inflammatory bowel disease who are about to start a new biologic therapy or have never taken one before.
Hear when a new Intestinal Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.